M G Peters

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin
    M G Peters
    University of California at San Francisco, 94143, USA
    Transplantation 68:1912-4. 1999
  2. ncbi request reprint Animal models of autoimmune liver disease
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, California 94143 0538, USA
    Immunol Cell Biol 80:113-6. 2002
  3. ncbi request reprint Alcohol use and hepatitis C
    Marion G Peters
    Department of Gastroenterology, University of California, San Francisco, CA 94143, USA
    Hepatology 36:S220-5. 2002
  4. ncbi request reprint Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, CA 94143, USA
    Gastroenterology 126:91-101. 2004
  5. ncbi request reprint Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis
    J C Lai
    Department of Medicine, Division of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco, CA
    Am J Transplant 13:2611-8. 2013
  6. pmc Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis
    Debika Bhattacharya
    University of California, Los Angeles, CA, USA
    J Acquir Immune Defic Syndr 55:170-5. 2010
  7. ncbi request reprint Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
    Marion G Peters
    University of California, San Francisco, San Francisco, CA, USA
    Hepatology 44:1110-6. 2006
  8. ncbi request reprint Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects
    Caroline M Behler
    Department of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143 1270, USA
    Clin Infect Dis 44:1375-83. 2007
  9. ncbi request reprint Viral hepatitis in HIV infection
    Margaret James Koziel
    Division of Infectious Disease, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA
    N Engl J Med 356:1445-54. 2007
  10. pmc Influence of cannabis use on severity of hepatitis C disease
    Julie H Ishida
    Department of Medicine, University of California at San Francisco, San Francisco, California, USA
    Clin Gastroenterol Hepatol 6:69-75. 2008

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin
    M G Peters
    University of California at San Francisco, 94143, USA
    Transplantation 68:1912-4. 1999
    ..Mutations in the hepatitis B virus (HBV) genome may occur during therapy...
  2. ncbi request reprint Animal models of autoimmune liver disease
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, California 94143 0538, USA
    Immunol Cell Biol 80:113-6. 2002
    ..The plethora of antigens implicated in autoimmune hepatitis in humans predicts that multiple mechanisms may play a role in precipitating disease in the susceptible individual...
  3. ncbi request reprint Alcohol use and hepatitis C
    Marion G Peters
    Department of Gastroenterology, University of California, San Francisco, CA 94143, USA
    Hepatology 36:S220-5. 2002
    ..The literature is inadequate to provide definitive recommendations regarding the effect of light to moderate alcohol use in patients with hepatitis C...
  4. ncbi request reprint Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, CA 94143, USA
    Gastroenterology 126:91-101. 2004
    ....
  5. ncbi request reprint Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis
    J C Lai
    Department of Medicine, Division of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco, CA
    Am J Transplant 13:2611-8. 2013
    ..5%. Our analyses provide important data to facilitate the decision to implement HIV and HCV NAT for deceased SOT donors and shape national policy regarding how to reduce infection transmission in SOT...
  6. pmc Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis
    Debika Bhattacharya
    University of California, Los Angeles, CA, USA
    J Acquir Immune Defic Syndr 55:170-5. 2010
    ..In HIV/ hepatitis C virus (HCV) coinfection, adverse events (AEs) during HCV therapy account for 12%-39% of treatment discontinuations. It is unknown whether sex influences complications...
  7. ncbi request reprint Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
    Marion G Peters
    University of California, San Francisco, San Francisco, CA, USA
    Hepatology 44:1110-6. 2006
    ..In conclusion, over 48 weeks, treatment with either ADV or TDF resulted in clinically important suppression of serum HBV DNA. Both drugs are safe and efficacious for patients coinfected with HBV and HIV...
  8. ncbi request reprint Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects
    Caroline M Behler
    Department of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143 1270, USA
    Clin Infect Dis 44:1375-83. 2007
    ....
  9. ncbi request reprint Viral hepatitis in HIV infection
    Margaret James Koziel
    Division of Infectious Disease, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA
    N Engl J Med 356:1445-54. 2007
  10. pmc Influence of cannabis use on severity of hepatitis C disease
    Julie H Ishida
    Department of Medicine, University of California at San Francisco, San Francisco, California, USA
    Clin Gastroenterol Hepatol 6:69-75. 2008
    ..Complications of HCV infection are primarily related to the development of advanced fibrosis and whether cannabis use is a risk factor for more severe fibrosis is controversial...
  11. ncbi request reprint Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States
    Marion G Peters
    University of California at San Francisco, San Francisco, CA 94143 0538, USA
    Hepatology 46:769-75. 2007
    ..However, the mean age, male-to-female ratio, and seroprevalence of AMA positivity were similar between the 2 groups...
  12. ncbi request reprint Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis
    Burton Combes
    The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Hepatology 42:1184-93. 2005
    ..In conclusion, methotrexate when added to UDCA for a median period of 7.6 years had no effect on the course of PBC treated with UDCA alone...
  13. ncbi request reprint Managing hepatitis B coinfection in HIV-infected patients
    Marion G Peters
    Division of Gastroenterology, Box 0538, University of California, 513 Parnassus Ave, Room S 357, San Francisco, CA 94143 0538, USA
    Curr HIV/AIDS Rep 2:122-6. 2005
    ..Long-term management of hepatitis B includes monitoring for hepatocellular carcinoma. Two recent consensus conferences have provided excellent reviews of management of coinfection ...
  14. ncbi request reprint Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients
    Kenneth E Sherman
    Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Gastroenterology 128:313-27. 2005
    ..HCV-monoinfected patients. Reasons for this remain unclear. This study evaluated kinetic parameters and treatment responses in co-infected vs monoinfected patients...
  15. ncbi request reprint Antiviral therapy: nucleotide and nucleoside analogs
    David J Quan
    Department of Clinical Pharmacy, University of California, San Francisco, 521 Parnassus Avenue, Room C 152, Box 0622, San Francisco, CA 94143 0622, USA
    Clin Liver Dis 8:371-85. 2004
    ..Other nucleoside analogs are in various stages of development, including MCC-478 and DAPD. In the future, clinicians will have a plethora of reagents to chose from, and combination therapies may be invoked...
  16. ncbi request reprint Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
    Raymond T Chung
    Massachusetts General Hospital, Boston, MA 02114, USA
    N Engl J Med 351:451-9. 2004
    ..We conducted a multicenter, randomized trial comparing peginterferon plus ribavirin with interferon plus ribavirin for the treatment of chronic hepatitis C in persons coinfected with HIV...
  17. ncbi request reprint Diagnosis and management of hepatitis B virus and HIV coinfection
    Marion G Peters
    Hepatology Research, University of California San Francisco, San Francisco, CA, USA
    Top HIV Med 15:163-6. 2007
    ..This article summarizes a presentation on HIV and HBV coinfection made by Marion G. Peters, MD, at an International AIDS Society-USA Continuing Medical Education course in San Francisco in May 2007...
  18. ncbi request reprint Role of alphavbeta6 integrin in acute biliary fibrosis
    Bruce Wang
    Liver Center, Department of Medicine, University of California, San Francisco, USA
    Hepatology 46:1404-12. 2007
    ..In a survey of human liver disease, expression of alphavbeta6 is increased in acute, but not chronic, biliary injury and is localized to cholangiocyte-like cells...
  19. doi request reprint The challenge of diagnosing autoimmune hepatitis: less is more
    Gina Choi
    Hepatology 48:10-2. 2008
  20. ncbi request reprint Viral factors associated with cytokine expression during HCV/HIV co-infection
    Jason T Blackard
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    J Interferon Cytokine Res 27:263-9. 2007
    ..Further studies are warranted to identify noninvasive markers of liver disease for the clinical management of HCV disease, particularly when liver biopsies have not been performed or are contraindicated...
  21. ncbi request reprint Effects of HCV treatment on cytokine expression during HCV/HIV coinfection
    Jason T Blackard
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    J Interferon Cytokine Res 26:834-8. 2006
    ....
  22. ncbi request reprint Novel model of antigen-specific induction of bile duct injury
    James Buxbaum
    Department of Medicine, University of California, San Francisco, California 94143 0538, USA
    Gastroenterology 131:1899-906. 2006
    ..Biliary-directed inflammation is an important cause of acute and chronic liver disease. We developed and characterized a transgenic mouse model of immune-mediated hepatobiliary injury...
  23. ncbi request reprint Hepatitis C and alcohol: fundamental and translational research directions
    Timothy R Morgan
    Department of Medicine, Veterans Adminstration Medical Center, Long Beach, California, USA
    Alcohol Clin Exp Res 27:726-31. 2003
    ..This article summarizes the panel's deliberations and their recommendations for future research on alcohol and hepatitis C...
  24. ncbi request reprint De novo malignancies following liver transplantation: a case-control study with long-term follow-up
    Francis Y Yao
    Department of Medicine, University of California San Francisco, San Francisco, CA 94143 0538, USA
    Clin Transplant 20:617-23. 2006
    ..Long-term survival data on de novo malignancy are limited following orthotopic liver transplantation (OLT) when compared with controls without malignancies...
  25. ncbi request reprint Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant
    Jennifer E Guy
    Department of Medicine, University of California San Francisco, CA 94143 0538, USA
    Liver Transpl 11:1252-7. 2005
    ..In conclusion, recurrent PBC is not infrequent post-OLT, and ursodeoxycholic acid can be used with some benefit post-OLT. Treatment effects on long-term survival are not known...
  26. pmc Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis
    Burton Combes
    University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9151, USA
    Am J Gastroenterol 99:264-8. 2004
    ....